Literature DB >> 18988092

Quantitative relationships between patch test reactivity and use test reactivity: an overview.

Danny Zaghi1, Howard I Maibach.   

Abstract

Use tests such as the provocative use test (PUT) or repeated open application test (ROAT) have been created to better understand the clinical significance of patch test results. It has been suggested that since these tests typically utilize only one substance at a time and avoid occlusion, they minimize the occurrence of irritation and false positives and, thus, are more reflective of real-life exposure to an allergen. In this analysis, we compare and analyze different studies comparing patch test and use test reactivity. With regard to colophony, cinnamic aldehyde, methyldibromo glutaronitrile, 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one, and isoeugenol, increased patch test sensitivity resulted in increased use test sensitivity. However, this was not true for formaldehyde or chromium. The reason for the latter allergens' divergence from the trend is not yet understood. Additionally, we note the presence of an increasing slope in the relationship between use test reactivity and minimum eliciting concentration on patch testing for methyldibromo glutaronitrile. Expansion of databases relating serial dilution patch test reactivity and use test data should aid dermatologic management, public health policy, and an understanding of the complexity of allergic contact dermatitis in humans.

Entities:  

Mesh:

Year:  2008        PMID: 18988092     DOI: 10.1080/15569520802251130

Source DB:  PubMed          Journal:  Cutan Ocul Toxicol        ISSN: 1556-9527            Impact factor:   1.820


  2 in total

1.  Practical suggestions to improve standardization of repeated open application testing (ROAT) for daily use products.

Authors:  Feroze Kaliyadan; Puravoor Jayasree; Karalikkattil T Ashique
Journal:  Postepy Dermatol Alergol       Date:  2021-01-20       Impact factor: 1.664

Review 2.  In vivo studies of substances used in the cosmetic industry.

Authors:  Joanna Igielska-Kalwat; Joanna Gościańska; Beata Witkowska; Izabela Nowak
Journal:  Postepy Dermatol Alergol       Date:  2016-06-17       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.